Danaher Co. (NYSE:DHR) Stock Holdings Increased by PYA Waltman Capital LLC

PYA Waltman Capital LLC lifted its stake in Danaher Co. (NYSE:DHR) by 2.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 34,249 shares of the conglomerate’s stock after purchasing an additional 881 shares during the quarter. Danaher accounts for 2.5% of PYA Waltman Capital LLC’s portfolio, making the stock its 12th largest position. PYA Waltman Capital LLC’s holdings in Danaher were worth $7,862,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Kovack Advisors Inc. increased its holdings in Danaher by 3.4% in the 3rd quarter. Kovack Advisors Inc. now owns 1,243 shares of the conglomerate’s stock valued at $346,000 after buying an additional 41 shares during the period. Gilbert & Cook Inc. lifted its position in Danaher by 2.5% during the 4th quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock valued at $401,000 after purchasing an additional 42 shares during the period. Grimes & Company Inc. increased its stake in shares of Danaher by 0.6% in the 4th quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock valued at $1,696,000 after acquiring an additional 43 shares during the last quarter. Harbour Investments Inc. increased its stake in shares of Danaher by 3.0% in the 3rd quarter. Harbour Investments Inc. now owns 1,531 shares of the conglomerate’s stock valued at $426,000 after acquiring an additional 45 shares during the last quarter. Finally, Dakota Community Bank & Trust NA increased its stake in shares of Danaher by 16.4% in the 4th quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock valued at $73,000 after acquiring an additional 45 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price for the company in a research note on Thursday, October 31st. Citigroup cut their price objective on Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a report on Thursday, January 30th. Robert W. Baird cut their price objective on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. JPMorgan Chase & Co. cut their price objective on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Finally, StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Seven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 11.10% of the stock is currently owned by company insiders.

Danaher Trading Up 1.5 %

NYSE DHR opened at $208.10 on Friday. The company has a market cap of $150.31 billion, a price-to-earnings ratio of 39.41, a P/E/G ratio of 2.61 and a beta of 0.83. Danaher Co. has a 52 week low of $196.80 and a 52 week high of $281.70. The business has a 50 day moving average price of $227.21 and a 200-day moving average price of $247.52. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the business posted $2.09 EPS. As a group, equities analysts expect that Danaher Co. will post 7.67 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.32 per share. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.62%. Danaher’s dividend payout ratio is currently 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.